Clinical Trial Update: Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years

View source ↗

Summary

A pharmacometrics analysis of rivaroxaban in Chinese children over 2 years old is being conducted, with Kawasaki disease and coronary artery aneurysm as focus c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Aneurysm
• Kawasaki Disease

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Kawasaki Disease, Coronary Artery Aneurysm | Status: RECRUITING